Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.

[1]  S. Willsie.  Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma , 2010 .

[2]  Parameswaran Nair,et al.  Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. , 2009, The New England journal of medicine.

[3]  I. Pavord,et al.  Qualitative analysis of high-resolution CT scans in severe asthma. , 2009, Chest.

[4]  J. Fahy,et al.  Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. , 2009, Proceedings of the American Thoracic Society.

[5]  I. Pavord,et al.  Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. , 2009, The Journal of allergy and clinical immunology.

[6]  C. Guillén,et al.  A novel method for isolation of human lung T cells from lung resection tissue reveals increased expression of GAPDH and CXCR6 , 2009, Journal of immunological methods.

[7]  Mike Thomas,et al.  Cluster analysis and clinical asthma phenotypes. , 2008, American journal of respiratory and critical care medicine.

[8]  Kenji Matsumoto,et al.  Rapid and Strong Induction of Apoptosis in Human Eosinophils by Anti-CD30 mAb-Coated Microspheres and Phagocytosis by Macrophages , 2007, International Archives of Allergy and Immunology.

[9]  I. Pavord,et al.  Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma , 2007, Thorax.

[10]  N. Wilson,et al.  Does sputum eosinophilia predict the response to systemic corticosteroids in children with difficult asthma? , 2007, Pediatric pulmonology.

[11]  L. Boulet,et al.  Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations , 2006, European Respiratory Journal.

[12]  R. Scott,et al.  Inflammatory subtypes in asthma: Assessment and identification using induced sputum , 2006, Respirology.

[13]  C. Brightling.  Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines. , 2006, Chest.

[14]  I. Pavord,et al.  Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. , 2004, The Journal of allergy and clinical immunology.

[15]  I. Pavord,et al.  Comparison of airway immunopathology of eosinophilic bronchitis and asthma , 2003, Thorax.

[16]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[17]  I. Pavord,et al.  Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids , 2002, Thorax.

[18]  J. Douwes,et al.  Non-eosinophilic asthma: importance and possible mechanisms , 2002, Thorax.

[19]  G. Cohen,et al.  Interleukin-5 inhibits translocation of Bax to the mitochondria, cytochrome c release, and activation of caspases in human eosinophils. , 2001, Blood.

[20]  C. Jenkins,et al.  Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. , 2001, American journal of respiratory and critical care medicine.

[21]  J. Hankinson,et al.  Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. , 2000, American journal of respiratory and critical care medicine.

[22]  P. Barnes,et al.  Changes in sputum eosinophils predict loss of asthma control. , 2000, American journal of respiratory and critical care medicine.

[23]  D. Sexton,et al.  Resting and cytokine-stimulated human small airway epithelial cells recognize and engulf apoptotic eosinophils. , 1999, Blood.

[24]  P. Sterk,et al.  Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. , 1999, American journal of respiratory and critical care medicine.

[25]  I. Pavord,et al.  The use of induced sputum to investigate airway inflammation. , 1997, Thorax.

[26]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[27]  A. J. Wilson,et al.  Eosinophil apoptosis and the resolution of airway inflammation in asthma. , 1996, American journal of respiratory and critical care medicine.

[28]  A. Dvorak,et al.  Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome. , 1990, Laboratory investigation; a journal of technical methods and pathology.